Cardlytics Inc [NASDAQ: CDLX] surged by $0.55 during the normal trading session on Wednesday and reaching a high of $2.83 during the day while it closed the day at $2.64.
Cardlytics Inc stock has also gained 84.62% of its value over the past 7 days. However, CDLX stock has inclined by 60.00% in the 3 months of the year. Over the past six months meanwhile, it has gained 22.51% and lost -28.07% year-on date.
The market cap for CDLX stock reached $140.55 million, with 52.99 million shares outstanding and 50.33 million shares in the current float. Compared to the average trading volume of 4.44M shares, CDLX reached a trading volume of 34845731 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Cardlytics Inc [CDLX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CDLX shares is $1.62 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CDLX stock is a recommendation set at 3.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Evercore ISI have made an estimate for Cardlytics Inc shares, keeping their opinion on the stock as In-line, with their previous recommendation back on October 11, 2024. The new note on the price target was released on August 16, 2024, representing the official price target for Cardlytics Inc stock. Previously, the target price had yet another drop from $4 to $3.50, while BofA Securities kept a Underperform rating on CDLX stock.
The Price to Book ratio for the last quarter was 2.38, with the Price to Cash per share for the same quarter was set at 0.88.
CDLX stock trade performance evaluation
Cardlytics Inc [CDLX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 84.62. With this latest performance, CDLX shares gained by 142.20% in over the last four-week period, additionally plugging by 22.51% over the last 6 months – not to mention a drop of -28.84% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CDLX stock in for the last two-week period is set at 68.80, with the RSI for the last a single of trading hit 0.44, and the three-weeks RSI is set at 0.31 for Cardlytics Inc [CDLX]. The present Moving Average for the last 50 days of trading for this stock 1.57, while it was recorded at 2.41 for the last single week of trading, and 2.21 for the last 200 days.
Cardlytics Inc [CDLX]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Cardlytics Inc [CDLX] shares currently have an operating margin of -21.41% and a Gross Margin at 45.16%. Cardlytics Inc’s Net Margin is presently recorded at -68.87%.
Cardlytics Inc (CDLX) Capital Structure & Debt Analysis
According to recent financial data for Cardlytics Inc. ( CDLX), the Return on Equity (ROE) stands at -136.44%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -40.95%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Cardlytics Inc’s Return on Invested Capital (ROIC) is -79.05%, showcasing its effectiveness in deploying capital for earnings.
Cardlytics Inc (CDLX) Efficiency & Liquidity Metrics
Based on Cardlytics Inc’s (CDLX) latest financial statements, the Debt-to-Equity Ratio is 3.75%, indicating its reliance on debt financing relative to shareholder equity.
Cardlytics Inc (CDLX) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Cardlytics Inc. (CDLX) effectively leverages its workforce, generating an average of -$403832.6 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.16% and a Quick Ratio of 1.16%, indicating strong ability to cover short-term liabilities.
Earnings per share (EPS) analysis for Cardlytics Inc [CDLX] stock
With the latest financial reports released by the company, Cardlytics Inc posted -0.15/share EPS, while the average EPS was predicted by analysts to be reported at -0.27/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.12. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CDLX.
Cardlytics Inc [CDLX]: Institutional Ownership
There are presently around $45.78%, or 47.17%% of CDLX stock, in the hands of institutional investors. The top three institutional holders of CDLX stocks are: CAS INVESTMENT PARTNERS, LLC with ownership of 6.46 million shares, which is approximately 13.1785%. BLACKROCK INC., holding 3.15 million shares of the stock with an approximate value of $$25.88 million in CDLX stocks shares; and BLACKROCK INC., currently with $$19.81 million in CDLX stock with ownership which is approximately 4.9179%.
